Chappell John F

Avg. Two Year Performance

No purchase track record

(21%) Avg. Sale Return

(10%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(3%)	(6%)	(2%)	6%	(21%)
Sale Success Rate	5 of 10	3 of 10	6 of 10	5 of 8	1 of 6

Salix Pharmaceuticals Ltd.

Drugs » Drug Related Products

Director:

Holdings: 512.53K shares

Sentiment

Avg. Two Year Performance

No purchase track record

(21%) Sale Return (10%) Compound

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--